Announcements Call for Application for HEaL Institute’s Short-Duration Intensive Training Program of in Public Health Ethics to be held at Tata Institute of Social Sciences during April 14-17, 2020   |   Call for applications by The Migration Health South Asia Network for skill & capacity development training workshop to be held in 6-9 April 2020   |   Open Letter: Stop the war on Syria’s hospitals

The brand of generic prescriptions

BN Gangadhar, Santosh K Chaturvedi

DOI: 10.20529/IJME.2018.006


For some time now, a debate has been raging on the issue of generic drug prescriptions. Doctors are divided on this matter. Those against generic prescription cite possible poor quality and inadequate testing; while those in favour assert that the move would make cheaper medicines accessible to many more patients. The pharmaceutical industry attempts to introduce drug molecules that are safer and perhaps more effective. To enter the market each molecule would have been subjected to rigorous experimentation, at huge cost which needs to be recovered. The services of the industry are hence to be greatly appreciated, in spite of the criticism of the high pricing of their products.

Full Text





There are currently no refbacks.

Article Views

PDF Downloads

Click here to support US